Cartilaginous Eustachian tube length and carotid canal dehiscence in children: a radiological study
- 114 Downloads
The use of Balloon Eustachian tuboplasty (BET) for Eustachian tube dysfunction is increasing in adults but to a lesser extent in children. Despite growing experience, concerns remain that BET could theoretically cause carotid artery rupture, which may be more likely if there is carotid canal dehiscence adjacent to the bony Eustachian tube. This radiological study aims to assess the prevalence of carotid canal dehiscence and length of cartilaginous Eustachian tube in children.
Materials and methods
75 consecutive computed tomography scans of the petrous temporal bones performed in children were identified (150 carotid canals/Eustachian tubes). Two independent raters measured the length of the cartilaginous Eustachian tube and thickness of carotid canal wall.
8% of carotid canals had radiological dehiscence. Prevalence of carotid canal dehiscence on either side per child was 12%. Mean cartilaginous Eustachian tube length was 24.5 mm (SD 3.1 mm) and the minimum measured was 14.1 mm. The minimum length measured in a child over 3 years old (n = 65) was 18.1 mm. The mean thickness of bone of the carotid canal was 0.7 mm (SD 0.27 mm). There was a positive relationship between age and Eustachian tube length (Pearson’s correlation coefficient = 0.622, p < 0.001).
Carotid canal dehiscence in children has a low prevalence. Variation in the length of the cartilaginous Eustachian tube is low but is correlated with age. More research is required to define the indications, safety, efficacy and technical aspects of BET in children.
KeywordsCholesteatoma, Middle ear Eustachian tube Ear, Middle Tympanic membrane
The authors received no funding for this study.
Compliance with ethical standards
Conflict of interest
The authors have no conflicts of interest to declare.
All procedures performed in studies involving human participants were in accordance with the ethical standards of the institution (Plymouth Hospitals NHS Trust R&D approval reference 15/P/073) and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.
Due to the retrospective design of this radiological study and lack of study intervention, informed consent from the individual participants was deemed not required.
- 1.Han WG, Yoo J, Rah YC, Chang J, Im GJ, Song JJ, Chae SW, Jung HH, Choi J (2017) Analysis of Eustachian tube dysfunction by dynamic slow motion video endoscopy and Eustachian tube dysfunction questionnaire in chronic otitis media. Clin Exp Otorhinolaryngol 10(4):315–320. https://doi.org/10.21053/ceo.2016.01683 CrossRefPubMedPubMedCentralGoogle Scholar
- 5.Bluestone CD, Klein JO (1996) Otitis media, atelectasis, and Eustachian tube dysfunction. In: Bluestone CD, Stool SE, Kenna MA (eds) Pediatric otolaryngology, 3rd edn. WB Saunders, PhiladelphiaGoogle Scholar
- 8.NICE (2011) NICE interventional procedure guidance 409: Balloon dilatation of the Eustachian tube. NHS Evidence, LondonGoogle Scholar
- 16.United States Food and Drug Administration (2016) FDA permits marketing of balloon device to treat persistent Eustachian tube dysfunction. https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm521063.htm. Accessed March 2017. Washington DC